The Thai government has announced new regulatory edicts specifying tighter regulatory control over the use of hemp and CBD in food and seasonings, just three months after announcing the decriminalisation of cannabis in the country.
The Thai authorities have stressed that stringent control measures will be enforced as more food and beverage firm seeks to use cannabis-derived ingredients, amid claims that 30% of products contain higher than permitted tetrahydrocannabinol (THC) levels.
The Thai government has set its sights on emerging as the South East Asian regional leader in the areas of both organic food production and cannabis technology development, amid hopes that these sectors will help deliver a boost to the local economy.
Thailand supplement firm Nova Organic, which is well-known for its cordyceps products, is planning to expand into the other Asian markets after enjoying domestic success with middle-aged consumers.
Singapore is unlikely to permit the use of cannabidiol (CBD) in supplements in the near future, despite acknowledging it may have a role to play as a medicine.
Consumers suffering from chronic diseases or cancer could be vulnerable to the empty promises and misleading health claims, which is why Dr Janet Schloss, the latest guest on our NutraChampion podcast, has made it her mission to drive an evidence-based...
Thailand premium fruit juice market leader Tipco Foods is exploring new growth areas in the cannabidiol (CBD) foods, beverages, and herbal product space, the company’s CEO said in an exclusive interview.
The Indian firm behind an ayurvedic cannabis product for alleviating menstrual cramps has unveiled plans on expanding its product range to cover chronic pain relief.
In this round-up, we shine the spotlight on major brands, including Amorepacific’s new green tea probiotic, HempStreet’s first Ayurveda and cannabis product, and more.
Here's a recap of our 10 most read nutrition stories in May, featuring nutraceutical advancements in India, probiotic innovations across APAC, and the latest regulatory, infant nutrition, and nutricosmetics news in China.
Cannabis-based nutraceuticals and their APAC applications, probiotic innovations for mental and metabolic health, and the changing bone and joint health supplement sector make up our five most read stories on social media over the past month.
Supplements containing cannabidiol (CBD) and functional foods with hemp are among the biggest buzz categories in nutrition right now, but can they become mainstream commercial success stories in APAC?
CBD firm Bod Australia has embarked on a first-of-its-kind clinical trial on medical cannabis for Tourette syndrome patients, while continuing to expand its supplements business in countries with a more conducive regulatory environment than its home market.
Our latest science round-up features the gut health benefits of resveratrol and propolis, omega-3's effects on pregnancy and depression, and BioCeuticals' latest research on medicinal cannabis.
Australia's biggest hemp foods firm, which also has a cannabinoid (CBD) nutraceuticals and medical cannabis offering, launched today on the Australian Stock Exchange following a successful $20m IPO.
Canadian manufacturer Hempco says it will capitalize on new cannabis laws coming into force to move beyond foods based on hemp seeds into the market for CBD ingredients. The strategic play will help offset losses from a debacle in South Korea, where low...
Australian nutraceutical cannabinoid manufacturer Creso Pharma has signed a deal to market its flagship hemp-based product in Switzerland and Lichtenstein, shortly after announcing its market entry into China.
Cannabinoids can be safely used as a supplementary treatment for elderly people with Parkinson’s disease with evidence showing they help reduce tremors, rigidity and pain, a new review reports.
Industry and academic experts have been responding to Australia’s decision to establish a legal medicinal cannabis trade – with most welcoming it as a positive first step – while others are eagerly awaiting a judgement in April which will rule if hemp...
An anticipated perfect storm in Australia, involving the recent legalisation of medical cannabis and the expected approval of hemp in foods and nutrition later this year, has led to the government stopping the export of hemp products to ensure national...
A Chinese financial website and a private equity fund have sealed a deal to raise capital form mainland China to invest in the US cannabis supplements and functional beverage sectors.
Australian company Medlab Clinical Limited is preparing to start Australia’s first clinical trial using cannabis for oncology patients suffering intractable pain.
An Australian hemp pioneer has reacted with caution to a government proposal to allow the cultivation of cannabis in Australia for medical and scientific purposes.
Guest column, chief executive of Elixinol and Hemp Foods Australia
Once forgotten, cannabinoids and their medicinal benefits have recently been thrust back into the spotlight, in particular for their abilities to relieve often otherwise untreatable pain.
Though its hemp oil has not yet been approved as a medicine in New Zealand, one American supplier has been granted special permission to supply cannabidiol (CBD) oil to a teen there with a severe form of epilepsy.
